VF
ABEO icon

Virtu Financial’s Abeona Therapeutics ABEO Stock Holding History

Virtu Financial’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-34,615
Closed -$147K – 1303
2024
Q2 		$147K Buy
+34,615
New +$177K 0.01% 775
2023
Q3 		– Sell
-32,171
Closed -$130K – 1212
2023
Q2 		$130K Buy
+32,171
New +$113K 0.01% 950
2022
Q1 		– Sell
-10,025
Closed -$84K – 1438
2021
Q4 		$84K Buy
+10,025
New +$184K 0.01% 1196
2021
Q3 		– Sell
-566
Closed -$22K – 1437
2021
Q2 		$22K Sell
566
-1,683
-75% -$68.7K ﹤0.01% 1403
2021
Q1 		$106K Sell
2,249
-2,472
-52% -$136K 0.01% 1304
2020
Q4 		$185K Buy
4,721
+3,232
+217% +$110K 0.02% 888
2020
Q3 		$38K Buy
+1,489
New +$93.9K 0.01% 848
2019
Q3 		– Sell
-1,649
Closed -$197K – 1385
2019
Q2 		$197K Buy
+1,649
New +$276K 0.01% 1028
2018
Q1 		– Sell
-620
Closed -$246K – 1882
2017
Q4 		$246K Buy
+620
New +$256K 0.01% 1450

Other funds holding ABEO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Virtu Financial's ABEO Position: Q3 2024 in Review

Virtu Financial sold out of Abeona Therapeutics (ABEO) in Q3 2024, closing a stake of 34,615 shares — an estimated $147K sold.

Virtu Financial first reported a position in ABEO in Q4 2017 and held it in 9 quarters. The position peaked at $246K in Q4 2017. 55 funds tracked by Wall St. Rank hold ABEO as of Q3 2024.

  • Virtu Financial reported no remaining Abeona Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Virtu Financial sold 34,615 Abeona Therapeutics shares in Q3 2024, an estimated $147K.
  • Virtu Financial first reported a position in Abeona Therapeutics in Q4 2017 and held it in 9 quarters.
  • Virtu Financial's Abeona Therapeutics position peaked at $246K in Q4 2017.
  • 55 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2024.

Based on Virtu Financial's 13F filing for Q3 2024, filed 20 Nov 2024.